|Articles|March 1, 2002
- Applied Clinical Trials-03-01-2002
Consider Geography When Choosing Investigative Sites
An essential aspect of selecting the location for an investigative site is the population surrounding it. Here is a method for determining how many potential subjects are available to your investigators.
Advertisement
Articles in this issue
over 24 years ago
Meet the Editorial Advisory Board Francis Crawleyover 24 years ago
9th ACT European Summitover 24 years ago
Selecting Sites and Investigatorsover 24 years ago
Letters to the Editorover 24 years ago
Safety and Risk Assessment Gain Importanceover 24 years ago
Transporting Clinical Trial Samplesover 24 years ago
Forward to 2004 or Back to 1984?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
2
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
3
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
4
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
5